Even though the clinical relevance of your aforementioned cardiovascular threat factor alterations by tirzepatide will probably be assessed inside the planned cardiovascular final result review SURPASS-CVOT ( "kind":"medical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Eval